Company Special: Novartis Expands Drug Research Domestically

by swisscham in Engineering, Manufacturing

Swiss healthcare giant Novartis has committed $1 billion to the construction of a new R&D campus in Shanghai’s Zhangjiang High-Tech Park. Construction is well under way and once it is completed, the campus will be home to several Novartis divisions and the China Novartis Institutes for BioMedical Research. “We came to China to get access to the deep talent pool of scientists here,” said Mark Fishman, president of the Novartis Institutes for BioMedical Research, the company’s global pharmaceutical research arm. Indeed, Novartis has one of largest long-term R&D investments in the industry. In 2012, the company spent more than $9.1 billion on R&D, accounting for 16 percent of the $56.7 billion in net sales it saw that year.

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Your Swiss Business Platform in China

SwissCham China has roughly 600 company members. Our Chamber maintains a strong relationship with the Embassy of Switzerland, Swiss Global Enterprise, Swissnex and Switzerland Tourism. As the representative of the Swiss companies established in China, our goal is to help you to increase your business and visibility, especially amongst the Sino-Swiss business community.

Become A Member

Sign Up For Our Newsletter

  • This field is for validation purposes and should be left unchanged.
March 19, 2020
Published By thedriven.io in Engineering / Manufacturing
March 17, 2020
Published By textileworld.com in Engineering / Manufacturing
March 5, 2020
Published By moneycontrol.com in Hospitality / Tourism / Retail
March 4, 2020
Published By wkzo.com in Engineering / Manufacturing
March 2, 2020
Published By swissinfo.ch in Hospitality / Tourism / Retail